Markets After Canaccord Genuity and Roth Capital gave Delcath Systems (NASDAQ: DCTH) a Buy rating last month, the company received another Buy, this time from BTIG. Analyst Marie Thibault reiterated a Buy rating on Delcath Systems today and set a price target of $23.00. The company’s shares closed last Monday at $11.57. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 74.1% and a 61.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. Currently, the analyst consensus on Delcath Systems is a Strong Buy with an average price target of $24.00.